<DOC>
	<DOCNO>NCT01187186</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetics ( PK ) safety follow oral administration ASP1941 subject moderate hepatic impairment subject normal hepatic function base Child-Pugh Classification ( CPC ) .</brief_summary>
	<brief_title>A Study Assess Effect Hepatic Function Pharmacokinetics Safety ASP1941</brief_title>
	<detailed_description>Study drug orally administer Day 1 . Subjects admit clinic completion clinic discharge procedure Day 7 outpatient follow-up visit 6-9 day clinic discharge .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>Subjects Moderate Hepatic Impairment Agrees practice highly effective birth control 7 day post dose . If female , two year postmenopausal , surgically sterile , pregnant lactate Weights least 45 kg Body mass index 18 34 kg/m2 Meets criteria moderate hepatic impairment define ChildPugh method Subjects Normal Hepatic Function Agrees practice highly effective birth control 7 day post dose . If female , two year postmenopausal , surgically sterile , pregnant lactate Weights least 45 kg Body mass index 18 34 kg/m2 Must normal hepatic function define ChildPugh method Subjects Moderate Hepatic Impairment Has history presence biliary obstruction biliary disease , hepatic encephalopathy , advanced ascites , portal hypertension , esophageal /gastric variceal bleeding , hepatocellular carcinoma , previous liver transplantation . Has severe moderate renal dysfunction Known human immunodeficiency virus ( HIV ) positive Has clinically significant history presence illness , malignancy immunodeficiency Has blood transfusion donate / lose 450 mL blood within 60 day study drug administration donate plasma within 7 day prior clinical checkin Has history alcoholism drug/chemical/substance abuse within past 2 year Subjects Normal Hepatic Function Has severe moderate renal dysfunction Known human immunodeficiency virus ( HIV ) positive Has clinically significant history presence illness , malignancy immunodeficiency Has blood transfusion donate / lose 450 mL blood within 60 day study drug administration donate plasma within 7 day prior clinical checkin Has history alcoholism drug/chemical/substance abuse within past 2 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Liver disease</keyword>
	<keyword>ASP1941</keyword>
</DOC>